Covestor’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SL
Covestor's AMLX Position: Q3 2026 in Review
Covestor reduced its Amylyx Pharmaceuticals (AMLX) stake by 39% in Q3 2026, selling an estimated $345 and leaving 20 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2019.
Covestor first reported a position in AMLX in Q3 2022 and has held it in 11 quarters since. The position peaked at $55K in Q4 2023. 147 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- Covestor held 20 shares of Amylyx Pharmaceuticals worth $1K as of Q3 2026.
- Covestor sold 13 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $345.
- Amylyx Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2019 holding.
- Covestor first reported a position in Amylyx Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
- Covestor's Amylyx Pharmaceuticals position peaked at $55K in Q4 2023.
- 147 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.